JP2001523648A - 2種の活性剤を含むコンジュゲート - Google Patents
2種の活性剤を含むコンジュゲートInfo
- Publication number
- JP2001523648A JP2001523648A JP2000520816A JP2000520816A JP2001523648A JP 2001523648 A JP2001523648 A JP 2001523648A JP 2000520816 A JP2000520816 A JP 2000520816A JP 2000520816 A JP2000520816 A JP 2000520816A JP 2001523648 A JP2001523648 A JP 2001523648A
- Authority
- JP
- Japan
- Prior art keywords
- fibrinogen
- conjugate
- factor viii
- carrier
- microcapsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9724143.4A GB9724143D0 (en) | 1997-11-14 | 1997-11-14 | Pharmaceutical conjugate |
| GB9724143.4 | 1997-11-14 | ||
| PCT/GB1998/003442 WO1999025383A1 (en) | 1997-11-14 | 1998-11-16 | Conjugates comprising two active agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001523648A true JP2001523648A (ja) | 2001-11-27 |
| JP2001523648A5 JP2001523648A5 (cg-RX-API-DMAC10.html) | 2006-01-05 |
Family
ID=10822123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000520816A Pending JP2001523648A (ja) | 1997-11-14 | 1998-11-16 | 2種の活性剤を含むコンジュゲート |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7001989B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1047452B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2001523648A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE293459T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU1165899A (cg-RX-API-DMAC10.html) |
| DE (1) | DE69829880T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2238774T3 (cg-RX-API-DMAC10.html) |
| GB (1) | GB9724143D0 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1999025383A1 (cg-RX-API-DMAC10.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007507480A (ja) * | 2003-10-07 | 2007-03-29 | ヘモスタティクス リミテッド | 止血を促進するためのフィブリノゲン標的微粒子 |
| JP2011520913A (ja) * | 2008-05-16 | 2011-07-21 | バイエル・ヘルスケア・エルエルシー | 標的化凝固因子およびそれを使用する方法 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6933366B2 (en) * | 1996-12-27 | 2005-08-23 | Tripep Ab | Specificity exchangers that redirect antibodies to bacterial adhesion receptors |
| EP1089762A1 (de) * | 1998-06-10 | 2001-04-11 | Baxter Aktiengesellschaft | Konjugat, bestehend aus einem lektin und einem blutgerinnungsfaktor |
| GB9825105D0 (en) * | 1998-11-16 | 1999-01-13 | Andaris Ltd | Pharamaceutical conjugates |
| GB9827813D0 (en) * | 1998-12-17 | 1999-02-10 | Andaris Ltd | Pharmaceutical conjugates |
| DE19926475A1 (de) * | 1999-06-10 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Träger-Pharmaka-Konjugate |
| WO2001008709A1 (en) * | 1999-07-28 | 2001-02-08 | Valentis, Inc. | Sonoporation of tumors |
| ES2525585T3 (es) | 2006-05-05 | 2014-12-26 | The Regents Of The University Of Michigan | Intermedios para la preparación de miméticos de SMAC bivalentes |
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| US20090170195A1 (en) * | 2007-12-28 | 2009-07-02 | Kent State University | Curcumin-hyaluronan compounds |
| ES2427627T3 (es) * | 2009-04-06 | 2013-10-31 | Novo Nordisk A/S | Entrega dirigida de proteínas de Factor VIII a plaquetas |
| GB201101740D0 (en) * | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4970300A (en) * | 1985-02-01 | 1990-11-13 | New York University | Modified factor VIII |
| IL85372A (en) * | 1987-02-12 | 1992-12-01 | Us Health | Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them |
| US5716614A (en) | 1994-08-05 | 1998-02-10 | Molecular/Structural Biotechnologies, Inc. | Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier |
| DE69529917T2 (de) * | 1994-12-16 | 2003-12-11 | Elan Drug Delivery Ltd., Ruddington | Vernetzte mikropartikel und ihre verwendung als arzneiträger |
| EP0831793A4 (en) | 1995-06-06 | 2000-11-15 | Hemosphere Inc | PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE |
| AU718956B2 (en) | 1996-10-21 | 2000-05-04 | Quadrant Healthcare (Uk) Limited | Platelet substitutes and conjugation methods suitable for their preparation |
-
1997
- 1997-11-14 GB GBGB9724143.4A patent/GB9724143D0/en not_active Ceased
-
1998
- 1998-11-16 WO PCT/GB1998/003442 patent/WO1999025383A1/en not_active Ceased
- 1998-11-16 AT AT98954603T patent/ATE293459T1/de active
- 1998-11-16 DE DE69829880T patent/DE69829880T2/de not_active Expired - Lifetime
- 1998-11-16 ES ES98954603T patent/ES2238774T3/es not_active Expired - Lifetime
- 1998-11-16 AU AU11658/99A patent/AU1165899A/en not_active Abandoned
- 1998-11-16 JP JP2000520816A patent/JP2001523648A/ja active Pending
- 1998-11-16 EP EP98954603A patent/EP1047452B1/en not_active Expired - Lifetime
-
2002
- 2002-11-22 US US10/302,428 patent/US7001989B2/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007507480A (ja) * | 2003-10-07 | 2007-03-29 | ヘモスタティクス リミテッド | 止血を促進するためのフィブリノゲン標的微粒子 |
| JP2011520913A (ja) * | 2008-05-16 | 2011-07-21 | バイエル・ヘルスケア・エルエルシー | 標的化凝固因子およびそれを使用する方法 |
| US9422362B2 (en) | 2008-05-16 | 2016-08-23 | Bayer Healthcare Llc | Targeted coagulation factors and method of using the same |
| JP2017025065A (ja) * | 2008-05-16 | 2017-02-02 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 標的化凝固因子およびそれを使用する方法 |
| US10035840B2 (en) | 2008-05-16 | 2018-07-31 | Bayer Healthcare Llc | Targeted coagulation factors and method of using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1165899A (en) | 1999-06-07 |
| EP1047452A1 (en) | 2000-11-02 |
| WO1999025383A1 (en) | 1999-05-27 |
| GB9724143D0 (en) | 1998-01-14 |
| DE69829880T2 (de) | 2005-09-22 |
| US7001989B2 (en) | 2006-02-21 |
| EP1047452B1 (en) | 2005-04-20 |
| ES2238774T3 (es) | 2005-09-01 |
| DE69829880D1 (de) | 2005-05-25 |
| ATE293459T1 (de) | 2005-05-15 |
| US20030087826A1 (en) | 2003-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2269335C (en) | Platelet substitutes and conjugation methods suitable for their preparation | |
| US5258499A (en) | Liposome targeting using receptor specific ligands | |
| JP4350165B2 (ja) | 架橋した微細粒子、及びそれら粒子の治療薬用ビヒクルとしての使用 | |
| US4671958A (en) | Antibody conjugates for the delivery of compounds to target sites | |
| ES2266041T3 (es) | Proteina serica y celular de anclaje y conjugados. | |
| US5955108A (en) | Cross-linked microparticles and their use as therapeutic vehicles | |
| JP2000509394A (ja) | 細胞膜を横切って物質を輸送するためのポリペプチド結合体 | |
| JPH07508004A (ja) | プロテイノイド担体並びにその製造方法および使用方法 | |
| EP1047452B1 (en) | Conjugates comprising two active agents | |
| US20040180094A1 (en) | Activation agents on the surface of encapsulation vesicles | |
| US20090203619A1 (en) | Artificial platelets | |
| JP2001523648A5 (cg-RX-API-DMAC10.html) | ||
| JPH10158195A (ja) | 配位結合を利用した薬物−高分子複合体製剤の調製方法 | |
| US20170349644A1 (en) | Factor viii with extended half-life and reduced ligand-binding properties | |
| AU754117B2 (en) | Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells | |
| KR20050111583A (ko) | 펩티드 결합체 | |
| WO2000035487A1 (en) | Pharmaceutical conjugates comprising two active agents | |
| WO2000029028A1 (en) | Pharmaceutical conjugates of glycoproteins and insoluble carriers | |
| MXPA99003677A (en) | Platelet substitutes and conjugation methods suitable for their preparation | |
| US20040235719A1 (en) | Soluble protein-polymer systems for drug delivery | |
| CN1240364A (zh) | 血小板替代物和适于其制备的缀合方法 | |
| AU2002255172A1 (en) | Soluble protein-polymer systems for drug delivery | |
| JPH06508114A (ja) | パリトキシン関連プロドラッグおよびその投与方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20040220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050921 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050921 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090507 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090806 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090813 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091109 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100302 |